Dr. Yoshio Kato, a noted researcher in chromatography, has passed away. Kato was a quiet personality who presented scientific findings in simple, understandable words, and he was a good friend. He passed away at the end of August 2015, at the age of 70.
Dr. Yoshio Kato, a noted researcher in chromatography, has passed away. Kato was a quiet personality who presented scientific findings in simple, understandable words, and he was a good friend. He passed away at the end of August 2015, at the age of 70.
Kato graduated from Nagoya University and worked all of his business life for Tosoh Corporation, where he was the pioneer in protein chromatography. The silica-based, large pore, hydrophilic TSKgel G3000SW column that he developed at end of the 1970s was the first to separate plasma proteins analytically in high resolution. That column is listed in both US and EU pharmacopeias as the reference in plasma protein analysis. He also helped develop, a highly crosslinked polymethacrylate resin for analytical purpose, called PW. For industrial applications, to separate proteins in large scale, they were performed on the polymethacrylate resin Toyopearl, which he codeveloped 1979. During the last decade of his professional life, he was involved in the development of various affinity materials. He retired in 2005.
Kato was always very knowledgeable and pleasant company during scientific meetings and marketing events that he liked to attend all over the world. In particular, he enjoyed eating big, medium fried steaks when traveling in the United States.
After retirement he started a company and worked as a consultant in the field of high performance liquid chromatography (HPLC), but reserved enough time for golfing with buddies and traveling with his wife.
For many people in the scientific community, especially in protein separation, he was a good comrade and we will miss him very much. Many friends and companions-including Peter Foeldi, formerly with LKB; Juergen Friedle, formerly with E. Merck and Tosoh Bioscience GmbH; Egbert Müller of Tosoh Bioscience GmbH; and Koji Nakamura formerly with Tosoh corporation-would like to say good-bye. Many more good friends and scientific colleagues could also be listed; we will not forget him.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.